- Home
- BHE vs SLNO Comparison
BHE vs SLNO Comparison
Compare BHE & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHE | SLNO |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BHE | SLNO |
|---|---|---|
| Price | $55.23 | $33.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $55.00 | ★ $105.27 |
| AVG Volume (30 Days) | 262.7K | ★ 1.4M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | ★ 0.68 | 0.39 |
| Revenue | ★ $2,659,108,000.00 | $1,450,788.00 |
| Revenue This Year | $6.84 | $150.65 |
| Revenue Next Year | $6.02 | $56.10 |
| P/E Ratio | ★ $82.35 | $85.97 |
| Revenue Growth | 0.11 | ★ 138.82 |
| 52 Week Low | $30.73 | $32.15 |
| 52 Week High | $61.12 | $89.12 |
Technical Indicators
Market Signals| Indicator | BHE | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 35.15 |
| Support Level | $42.45 | $32.63 |
| Resistance Level | $60.82 | $41.48 |
| Average True Range (ATR) | 1.84 | 1.79 |
| MACD | -0.23 | -0.41 |
| Stochastic Oscillator | 50.70 | 17.37 |
Price Performance
Historical ComparisonAbout BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.